APA (7th ed.) Citation

Nakai, S., Makino, T., Momose, K., Yamashita, K., Tanaka, K., Miyata, H., . . . Doki, Y. (2025). Exploring predictive biomarkers of efficacy and survival with nivolumab treatment for unresectable/recurrent esophageal squamous cell carcinoma. Esophagus, 1-13. https://doi.org/10.1007/s10388-025-01120-z

Chicago Style (17th ed.) Citation

Nakai, Shigeto, et al. "Exploring Predictive Biomarkers of Efficacy and Survival with Nivolumab Treatment for Unresectable/recurrent Esophageal Squamous Cell Carcinoma." Esophagus 2025: 1-13. https://doi.org/10.1007/s10388-025-01120-z.

MLA (9th ed.) Citation

Nakai, Shigeto, et al. "Exploring Predictive Biomarkers of Efficacy and Survival with Nivolumab Treatment for Unresectable/recurrent Esophageal Squamous Cell Carcinoma." Esophagus, 2025, pp. 1-13, https://doi.org/10.1007/s10388-025-01120-z.